Literature DB >> 32053752

Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon.

Sönke Andres1, Matthias Merker1,2, Jan Heyckendorf1,2, Barbara Kalsdorf1,2, Rudolf Rumetshofer3, Alexander Indra4, Sabine Hofmann-Thiel5,6,7, Harald Hoffmann5,6,7, Christoph Lange1,2,8,9, Stefan Niemann1,2, Florian P Maurer1,10.   

Abstract

Entities:  

Year:  2020        PMID： 32053752     DOI： 10.1164/rccm.201909-1819LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  19 in total

1.  Characterization of Genomic Variants Associated with Resistance to Bedaquiline and Delamanid in Naive Mycobacterium tuberculosis Clinical Strains.

Authors:  S Battaglia; A Spitaleri; A M Cabibbe; C J Meehan; C Utpatel; N Ismail; S Tahseen; A Skrahina; N Alikhanova; S M Mostofa Kamal; A Barbova; S Niemann; R Groenheit; A S Dean; M Zignol; L Rigouts; D M Cirillo
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

2.  Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis Complex.

Authors:  Roger Vargas; Luca Freschi; Andrea Spitaleri; Sabira Tahseen; Ivan Barilar; Stefan Niemann; Paolo Miotto; Daniela Maria Cirillo; Claudio U Köser; Maha R Farhat
Journal:  Antimicrob Agents Chemother       Date:  2021-08-30       Impact factor: 5.938

3.  Whole Genome Sequencing Identifies Novel Mutations Associated With Bedaquiline Resistance in Mycobacterium tuberculosis.

Authors:  Qinglong Guo; Jing Bi; Qiao Lin; Taosheng Ye; Zhongyuan Wang; Zhaoqin Wang; Lei Liu; Guoliang Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-05-27       Impact factor: 6.073

4.  Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan.

Authors:  P Nair; T Hasan; K K Zaw; S Allamuratova; A Ismailov; P Mendonca; Z Bekbaev; N Parpieva; J Singh; N Sitali; E Bermudez-Aza; A Sinha
Journal:  Int J Tuberc Lung Dis       Date:  2022-07-01       Impact factor: 3.427

5.  Design of Multidrug-Resistant Tuberculosis Treatment Regimens Based on DNA Sequencing.

Authors:  Hans-Peter Grobbel; Matthias Merker; Niklas Köhler; Sönke Andres; Harald Hoffmann; Jan Heyckendorf; Maja Reimann; Ivan Barilar; Viola Dreyer; Doris Hillemann; Barbara Kalsdorf; Thomas A Kohl; Patricia Sanchez Carballo; Dagmar Schaub; Katharina Todt; Christian Utpatel; Florian P Maurer; Christoph Lange; Stefan Niemann
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

6.  MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era.

Authors:  Patrick Beckert; Elisabeth Sanchez-Padilla; Matthias Merker; Viola Dreyer; Thomas A Kohl; Christian Utpatel; Claudio U Köser; Ivan Barilar; Nazir Ismail; Shaheed Vally Omar; Marisa Klopper; Robin M Warren; Harald Hoffmann; Gugu Maphalala; Elisa Ardizzoni; Bouke C de Jong; Bernhard Kerschberger; Birgit Schramm; Sönke Andres; Katharina Kranzer; Florian P Maurer; Maryline Bonnet; Stefan Niemann
Journal:  Genome Med       Date:  2020-11-25       Impact factor: 11.117

7.  Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis.

Authors:  Camus Nimmo; James Millard; Lucy van Dorp; Kayleen Brien; Sashen Moodley; Allison Wolf; Alison D Grant; Nesri Padayatchi; Alexander S Pym; François Balloux; Max O'Donnell
Journal:  Lancet Microbe       Date:  2020-08

8.  Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis.

Authors:  Nabila Ismail; Emmanuel Rivière; Jason Limberis; Stella Huo; John Z Metcalfe; Rob M Warren; Annelies Van Rie
Journal:  Lancet Microbe       Date:  2021-08-31

9.  Adjunctive surgery versus medical treatment among patients with cavitary multidrug-resistant tuberculosis.

Authors:  Sergo A Vashakidze; Shota G Gogishvili; Ketino G Nikolaishvili; Zaza R Avaliani; Abivarma Chandrakumaran; Giorgi Sh Gogishvili; Mathew Magee; Henry M Blumberg; Russell R Kempker
Journal:  Eur J Cardiothorac Surg       Date:  2021-12-01       Impact factor: 4.534

10.  Potency boost of a Mycobacterium tuberculosis dihydrofolate reductase inhibitor by multienzyme F420H2-dependent reduction.

Authors:  Wassihun Wedajo Aragaw; Brendon M Lee; Xuan Yang; Matthew D Zimmerman; Martin Gengenbacher; Véronique Dartois; Wai-Keung Chui; Colin J Jackson; Thomas Dick
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-22       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.